I. Bazin
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Neurology top 5%
- Barrier Structure and Function Studies
Papers in
- Oncology 17
- Pancreatic and Hepatic Oncology Research 12
- Colorectal Cancer Treatments and Studies 6
-
- Gastric Cancer Management and Outcomes 8
- Renal cell carcinoma treatment 4
- Advanced Breast Cancer Therapies 2
- Co-authors
- Bohuslav Melichar (10 shared papers)August Garin (1 shared paper)A. V. Lichtenstein (1 shared paper)Samuil R. Umansky (1 shared paper)В И Кныш (1 shared paper)Igor Bondarenko (8 shared papers)I. V. Botezatu (1 shared paper)В. П. Шелепов (1 shared paper)
In The Last Decade
I. Bazin
26 papers receiving 1.0k citations
I. Bazin's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 299
- Neurology 127
- Oncology 370
- Gastroenterology 60
- Pulmonary and Respiratory Medicine 297
Countries citing papers authored by I. Bazin
This map shows the geographic impact of I. Bazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Bazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Bazin more than expected).
Fields of papers citing papers by I. Bazin
This network shows the impact of papers produced by I. Bazin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Bazin. The network helps show where I. Bazin may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Bazin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 313 | |
| 2 | FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma Hit paper breakdown → | 2021 | 268 |
| 3 | 2018 | 76 | |
| 4 | 2016 | 53 | |
| 5 | 2010 | 51 | |
| 6 | 2016 | 50 | |
| 7 | 2016 | 44 | |
| 8 | 2016 | 35 | |
| 9 | 2016 | 26 | |
| 10 | 2015 | 19 | |
| 11 | 2016 | 18 | |
| 12 | 2007 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2016 | 9 | |
| 15 | 2017 | 7 | |
| 16 | 2019 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 1999 | 3 | |
| 19 | Clinical Predictors of Second-Line Chemotherapy Benefit in Patients with Pancreatic Cancer | 2017 | 2 |
| 20 | 2016 | 2 |
About I. Bazin
I. Bazin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Neurology, Epidemiology and Cancer Research, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers), Barrier Structure and Function Studies (5 papers), Renal cell carcinoma treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Cancer Research (299 citations), Neurology (127 citations), Oncology (370 citations), Gastroenterology (60 citations) and Pulmonary and Respiratory Medicine (297 citations). I. Bazin has collaborated with scholars based in Russia, Germany and Czechia. Frequent co-authors include Bohuslav Melichar, August Garin, A. V. Lichtenstein, Samuil R. Umansky, В И Кныш, Igor Bondarenko, I. V. Botezatu, В. П. Шелепов, Hovsep Melkonyan and Г. И. Потапова. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Chemistry, International Journal of Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.